Every motor carrier that operates commercial vehicles requiring a commercial driver's license is a DOT regulated employer for drug and alcohol testing purposes. The Federal Motor Carrier Safety Administration enforces a controlled substances and alcohol testing program under 49 CFR Part 382, and the collection, laboratory, and reporting procedures for that program sit in 49 CFR Part 40, the rule that governs drug and alcohol testing across every mode of transportation the Department of Transportation regulates. A written trucking company drug testing policy has to track both parts, and it typically goes further to cover roles and situations the federal rule does not touch.
This article lays out what the federal rule actually requires, where carriers commonly add their own policy language, and where the rule is still evolving. It is general information for carrier safety and HR staff, not legal advice. Policy language should be reviewed by qualified counsel before it is adopted.
Who the federal rule covers
Part 382 applies to any person who operates a commercial motor vehicle that requires a commercial driver's license under 49 CFR Part 383, and to the employer of that person, once the vehicle is operated in commerce. This includes most interstate and many intrastate combination and straight truck operations above the weight and configuration thresholds in Part 383. Drivers who never need a CDL, such as light duty delivery staff in vehicles under the CDL threshold, are not covered by Part 382 for that role, even though the company employing them is a trucking or logistics company. Carriers that also run non CDL fleets usually decide, as a matter of company policy rather than federal mandate, to test those employees too. That decision and its design are entirely the carrier's to make, subject to applicable state law.
The required test types and what triggers each one
Part 382 sets out a defined list of testing events. A compliant policy has to address each one, because the triggers, not the carrier's preference, decide when a test happens.
| Test type | What triggers it | Key rule |
|---|---|---|
| Pre-employment | Before a driver first performs any safety sensitive function for the employer | Part 382 Subpart C; a verified negative drug result is required before driving begins |
| Random | Unannounced, unpredictable selection from the carrier's driver pool through the year, at or above the minimum annual percentage rate FMCSA sets for the testing cycle | 49 CFR 382.305 |
| Post-accident | Fatality, or a citation issued to the CMV driver along with either a vehicle towed from the scene or a person requiring immediate medical treatment away from the scene | 49 CFR 382.303 |
| Reasonable suspicion | A trained supervisor's specific, contemporaneous observations of appearance, behavior, speech, or odor consistent with drug or alcohol use | 49 CFR 382.307 |
| Return-to-duty | Before a driver who violated the drug and alcohol rule may resume safety sensitive duties, after completing evaluation and treatment with a Substance Abuse Professional | 49 CFR 382.309 and 49 CFR Part 40 Subpart O |
| Follow-up | A minimum of six unannounced tests in the first 12 months after return-to-duty, extendable by the SAP up to 60 months | 49 CFR Part 40 Subpart O |
The random testing rate is not fixed in the text of the rule as a single permanent number. FMCSA sets the applicable minimum annual percentage for controlled substances and for alcohol under the mechanism in 49 CFR 382.305, which ties the rate to the industry's reported positive result data. Carriers should confirm the currently applicable random testing percentage directly from FMCSA rather than relying on a number printed in an older policy or article, since the rate can change from one testing cycle to the next.
The five tested drug classes
DOT drug testing under Part 40 screens for five drug classes: marijuana metabolites, cocaine metabolites, amphetamines and methamphetamine (including MDMA), opioids, and phencyclidine. The opioid class was expanded in the HHS Mandatory Guidelines that Part 40 incorporates, adding semi-synthetic opioids such as oxycodone, oxymorphone, hydrocodone, and hydromorphone to the originally tested codeine and morphine. A nonnegative initial screen on a DOT specimen is always sent for confirmatory testing, and any result that could be explained by a legitimate prescription is referred to a Medical Review Officer before it can be reported as positive. Carriers should never try to interpret a lab result themselves or decide, outside the MRO process, whether a positive is excused.
Oral fluid testing: permitted, with a condition
Part 40 was amended to permit oral fluid as an alternative specimen type to urine for DOT testing. The provisions for oral fluid collection, including the two collector requirement at the time of collection, sit in Subpart E of Part 40. Oral fluid testing under a DOT program can only be used once the Department of Health and Human Services has certified at least two laboratories to perform oral fluid testing to the federal standard. Carriers that want to add oral fluid as an option, or that are asked by a driver about it, should confirm the current laboratory certification status directly through the federal rule and FMCSA before changing a collection program, rather than assuming oral fluid is already available everywhere urine collection is used.
The Clearinghouse query duty
Since the FMCSA Drug and Alcohol Clearinghouse became mandatory, Part 382 Subpart G requires employers to query the Clearinghouse for violation information before hiring a driver or assigning a current employee to a safety sensitive function for the first time, and to run a query for every currently employed CDL driver at least once every 12 months. A full pre-employment query requires the driver's electronic consent in the system. Carriers also have reporting duties of their own: positive tests, test refusals, and other Part 382 violations by their drivers have to be reported into the Clearinghouse. The FMCSA Drug and Alcohol Clearinghouse is the system of record for both the query and reporting duties, and it is worth building query dates into the same calendar a carrier already uses to track CDL medical certificates and license renewals, since the annual query deadline does not reset itself.
What carriers commonly add beyond the federal minimum
A trucking company drug testing policy that only restates Part 382 and Part 40 usually leaves gaps a carrier's insurer, broker agreements, or state law will not accept. Common additions include:
- Non-CDL staff. Dispatchers, mechanics, warehouse workers, and non-CDL delivery drivers are not covered by Part 382. Carriers that choose to test this group do so under their own company policy and applicable state drug testing law, not under the DOT rule, and the two programs should be documented separately so a non-DOT result is never confused with a DOT result.
- Owner-operators. A single truck owner-operator who is their own employer still has to participate in a random testing pool, typically through a consortium or third party administrator, because one person cannot be their own "random" selection.
- Broader panel or lower cutoffs for the non-DOT program. Some carriers add substances to the non-DOT panel for non-CDL staff, such as synthetic cannabinoids or additional prescription opioids, which Part 40 does not test for.
- State-specific notice and consent language. A number of states require specific written notice, an employee's right to explain a positive result, or confirmation procedures beyond the federal minimum, and these obligations apply on top of, not instead of, the DOT rule. State requirements vary, and a carrier operating across state lines should confirm each state's current law rather than assume one policy template covers all of them.
Writing the policy itself
A usable policy document generally states, at minimum: which positions are DOT covered and which are not, the full list of test types and their triggers, the required Clearinghouse query points, who at the company is authorized to make a reasonable suspicion determination and what training that person has received, how a driver is removed from safety sensitive duty immediately upon a verified positive, refusal, or reasonable suspicion determination, and the return-to-duty and follow-up process including the role of the Substance Abuse Professional. It should also name the collection sites and laboratory or third party administrator the carrier uses, and state plainly that policy violations are handled under the federal rule's removal requirement, not at the carrier's discretion.
Frequently asked questions
Does a small carrier with only a few trucks have to follow the same rules as a large fleet?
Yes. Part 382 and Part 40 apply based on whether the vehicle requires a CDL and is operated in commerce, not based on fleet size. A one truck owner-operator and a thousand truck fleet follow the same test types, the same random testing mechanism, and the same Clearinghouse query duty, though smaller carriers typically use a consortium or third party administrator to manage the random pool and paperwork.
Can a trucking company set its own cutoff levels for a DOT test?
No. DOT drug and alcohol testing cutoff levels, procedures, and the chain of custody are fixed by the HHS Mandatory Guidelines incorporated into Part 40. A carrier cannot adopt its own cutoffs, add its own confirmation step, or bypass the Medical Review Officer process for a DOT specimen.
Is a trucking company required to test non-CDL warehouse or office staff?
No federal rule under Part 382 requires it, since that part only covers safety sensitive CDL functions. A carrier may choose to test other staff under its own policy, subject to state law, but that program is legally separate from the DOT program and should be labeled as such in the written policy.
Is oral fluid testing available for DOT drug tests right now?
Part 40 permits oral fluid as an alternative to urine, but only once HHS has certified at least two laboratories for oral fluid testing. Carriers should confirm current laboratory certification status before building oral fluid into a collection program, since availability depends on that certification milestone rather than the rule text alone.
How often does a carrier have to query the Clearinghouse for a current driver?
At least once every 12 months for each currently employed CDL driver, in addition to the required query before hiring or before first assigning a driver to a safety sensitive function. The Clearinghouse itself is the system carriers use to run and document both types of query.
What happens if a driver refuses a DOT required test?
A refusal is treated the same as a verified positive result under Part 40. The driver must be removed from safety sensitive functions immediately and cannot return until completing the full return-to-duty process with a Substance Abuse Professional, and the refusal is reportable to the Clearinghouse.
Related reading
For the query and reporting mechanics in more detail, see The FMCSA Clearinghouse: What Employers Need to Know. For the process a driver has to complete before resuming safety sensitive duty after a violation, see The DOT Return-to-Duty Drug Test Process: A Step-by-Step Guide for Employers.
Carriers setting up or restocking a DOT and non-DOT collection program can review DOT compliant drug test cups for site collections, and licensed distributors can review current case pricing through the American Screening wholesale portal.
This article is general information for carrier safety and HR staff, not legal advice. Confirm current federal and state requirements, and consult qualified counsel, before adopting or changing a drug and alcohol testing policy.
